Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by doctordeaconon Jan 17, 2017 4:33pm

103 Views

Post# 25719354

what if canopy is the silent partner

As i sit on my balcony of palmsplace the subtle wind on my nude body i light a cigar look at my asian lover take off her panties ...she smiles and asks why you so happy bigdaddy ....i take a puff of my hundred dollar cigar and reply ....we are going to be rich ,very rich off Newfarms ...she smiles and say ...oh i see and i smile stand up and make love to her on the balcony .

Bullboard Posts

Debt-free cannabis company set for next stage of growth